FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease , in CaliforniaSEOUL: South Korea has started distributing stocks of the COVID-19 treatment remdesivir which have been donated by Gilead Sciences, and plans to begin talks to purchase more supplies in August, its disease control agency said.
"Patients who are eligible for remdesivir are limited to severe patients with pneumonia and in need of oxygen therapy," the Korea Centres for Disease Control and Prevention said in a statement. it has priced remdesivir at US$390 per vial in the United States and other developed countries and agreed to send nearly all of its supply of the drug to the US over the next three months.South Korea has reported a total of 12,850 coronavirus cases as of Tuesday with 282 deaths.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: The Straits Times - 🏆 8. / 63 Read more »